Cargando…

Key Considerations for Phase 2 or 3 Clinical Study Design of Anti-Inflammatory Agent for COVID-19 Treatment

Purpose: Current understanding of COVID-19 disease progression suggests a major role for the “cytokine storm” as an important contributor to COVID-19 mortality. To prevent an exaggerated immune response and improve COVID-19 patient endpoints, anti-inflammatory therapeutics have been proposed as clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Yewon, Na, Joo Young, Cho, Joo-Youn, Oh, Jaeseong, Rhee, Su-jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201470/ https://www.ncbi.nlm.nih.gov/pubmed/35721224 http://dx.doi.org/10.3389/fphar.2022.842836

Ejemplares similares

Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease
por: Jin, Xuanyou, et al.
Publicado: (2020)

Andrographolide, a natural anti-inflammatory agent: An Update
por: Li, Xiaohong, et al.
Publicado: (2022)

Delivery of Antioxidant and Anti-inflammatory Agents for Tissue Engineered Vascular Grafts
por: Washington, Kenyatta S., et al.
Publicado: (2017)

Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment
por: Battogtokh, Gantumur, et al.
Publicado: (2018)

Diversity of Chromanol and Chromenol Structures and Functions: An Emerging Class of Anti-Inflammatory and Anti-Carcinogenic Agents
por: Wallert, Maria, et al.
Publicado: (2020)

Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic Fibrosis
por: Perrem, Lucy, et al.
Publicado: (2020)

Gaseous Mediators as a Key Molecular Targets for the Development of Gastrointestinal-Safe Anti-Inflammatory Pharmacology
por: Danielak, Aleksandra, et al.
Publicado: (2021)

Editorial: Anti-Inflammatory Agents in the Context of Age-Related Cardiometabolic Disease: Ethnopharmacological Perspectives
por: Arumugam, Somasundaram, et al.
Publicado: (2022)

Exploring the Leaves of Annona muricata L. as a Source of Potential Anti-inflammatory and Anticancer Agents
por: Abdul Wahab, Siti Mariam, et al.
Publicado: (2018)

Comparative Efficacy and Acceptability of Anti-inflammatory Agents on Major Depressive Disorder: A Network Meta-Analysis
por: Hang, Xiaoyi, et al.
Publicado: (2021)

Investigational Drugs for the Treatment of Depression (Part 1): Monoaminergic, Orexinergic, GABA-Ergic, and Anti-Inflammatory Agents
por: Vasiliu, Octavian
Publicado: (2022)

Pharmacological properties, molecular mechanisms and therapeutic potential of ginsenoside Rg3 as an antioxidant and anti-inflammatory agent
por: Wang, Jing, et al.
Publicado: (2022)

Design and Synthesis of l-1′-Homologated Adenosine Derivatives as Potential Anti-inflammatory Agents
por: Nguyen, Mai, et al.
Publicado: (2023)

Statistical considerations in long-term efficacy evaluation of anti-cancer therapies
por: Li, Ruobing, et al.
Publicado: (2023)

Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity
por: Oh, Jaeseong, et al.
Publicado: (2018)

Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders
por: Chen, Qian, et al.
Publicado: (2021)

Design, synthesis and screening of indole acetic acid-based tri-azo moieties as antioxidants, anti-microbial and cytotoxic agents
por: Javaid, Maryam, et al.
Publicado: (2023)

Polyphenols as Antitumor Agents Targeting Key Players in Cancer-Driving Signaling Pathways
por: Cháirez-Ramírez, Manuel Humberto, et al.
Publicado: (2021)

Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects
por: Rhee, Su-jin, et al.
Publicado: (2016)

The Analysis of Key Factors Related to ADCs Structural Design
por: Tang, Haichao, et al.
Publicado: (2019)

Noncanonical NF-κB Signaling Upregulation in Inflammatory Bowel Disease Patients is Associated With Loss of Response to Anti-TNF Agents
por: Nguyen, Vu Q., et al.
Publicado: (2021)

Dose-dependent reduction of lymphocyte count and heart rate after multiple administration of LC51-0255, a novel sphingosine-1-phosphate receptor 1 modulator, in healthy subjects
por: Hwang, Inyoung, et al.
Publicado: (2022)

Potent anti-inflammatory responses: Role of hydrogen in IL-1α dominated early phase systemic inflammation
por: Wei, Youzhen, et al.
Publicado: (2023)

Anti-cancer properties of boswellic acids: mechanism of action as anti-cancerous agent
por: Trivedi, Vijay Laxmi, et al.
Publicado: (2023)

Design considerations for early-phase clinical trials of immune-oncology agents
por: Wages, Nolan A., et al.
Publicado: (2018)

Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
por: Mitri, Christie, et al.
Publicado: (2020)

Arecae pericarpium water extract alleviates chronic pancreatitis by deactivating pancreatic stellate cells
por: Kweon, Bitna, et al.
Publicado: (2022)

Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
por: Ladin, Daniel A., et al.
Publicado: (2016)

Editorial: Targeted Subcellular Delivery of Anti-cancer Agents
por: Jans, David A., et al.
Publicado: (2019)

Beneficial Effects of Anisodamine in Shock Involved Cholinergic Anti-Inflammatory Pathway
por: Zhao, Ting, et al.
Publicado: (2011)

Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
por: Ribeiro, Carla Maria Pedrosa, et al.
Publicado: (2021)

Conventional reversal of rocuronium-induced neuromuscular blockade by sugammadex in Korean children: pharmacokinetics, efficacy, and safety analyses
por: Ji, Sang-Hwan, et al.
Publicado: (2023)

Editorial: Natural compounds regulating epigenetics for treating chronic inflammatory diseases
por: Zhang, Mingyu, et al.
Publicado: (2023)

Neuroprotective Effect of Catalpol via Anti-Oxidative, Anti-Inflammatory, and Anti-Apoptotic Mechanisms
por: Yang, Chunjing, et al.
Publicado: (2020)

Flavonoids as Natural Anti-Inflammatory Agents Targeting Nuclear Factor-Kappa B (NFκB) Signaling in Cardiovascular Diseases: A Mini Review
por: Choy, Ker Woon, et al.
Publicado: (2019)

Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
por: Weiskirchen, Ralf
Publicado: (2016)

Synthesis and Evaluations of Novel Apocynin Derivatives as Anti-Glioma Agents
por: Yang, Tao, et al.
Publicado: (2019)

Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
por: Ladin, Daniel A., et al.
Publicado: (2021)

Editorial: Inspired by Nature: Towards Novel Anti-Infective Agents
por: Ferreira, Ricardo J., et al.
Publicado: (2022)

Advances in thiosemicarbazone metal complexes as anti-lung cancer agents
por: Bai, Xian-Guang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_na1bib3koup82aj2brrk9phaoo